PBYI- Puma Biotechnology, Inc.

Name: Puma Biotechnology, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Puma Biotechnology, Inc. (PBYI) has 4 insiders with recent SEC Form 4 filings, including 0 buys and 16 sells. PBYI is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Auerbach Alan H	7.26M	$58.96M	-
CFO	Nougues Maximo F	240.0K	$1.95M	-
Other	Hunt Douglas M	205.3K	$1.67M	-
Dir	Miller Michael Patrick	54.0K	$438.5K	-

Activity

Buys and sells only

Transactions

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jul 6, 2026	Auerbach Alan H62	President And CEO	Sell	44,058	$8.26	$364,051.25	-0.6%	-	-
Jan 7, 2026	Hunt Douglas M62	See Remarks	Sell	8,987	$5.86	$52,695.52	-2.8%	+14.4%	-
Jan 7, 2026	Auerbach Alan H62	President And CEO	Sell	34,950	$5.86	$204,878.22	-0.2%	+14.4%	-
Jan 7, 2026	Nougues Maximo F61	Chief Financial Officer	Sell	10,945	$5.86	$64,186.76	-2.7%	+14.4%	-
Nov 11, 2025	Miller Michael Patrick46	Director	Sell	20,000	$4.86	$97,228.00	-27.0%	+32.6%	-
Jul 18, 2025	Cesano Alessandra	Director	Sell	27,000	$3.37	$90,909.00	-39.2%	+59.1%	+147.1%
Jul 9, 2025	Hunt Douglas M62	See Remarks	Sell	7,817	$3.53	$27,624.35	-2.3%	+43.9%	-
Jul 9, 2025	Auerbach Alan H62	President And CEO	Sell	47,172	$3.53	$166,701.84	-0.3%	+43.9%	-
Jul 9, 2025	Nougues Maximo F61	Chief Financial Officer	Sell	9,522	$3.53	$33,649.10	-2.3%	+43.9%	-
Jun 13, 2025	Cesano Alessandra	Director	Sell	12,150	$3.40	$41,310.00	-15.0%	+34.3%	+118.8%

Page 1Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC